Novel molecular biomarkers of cancer therapy-induced cardiotoxicity in adult population: a scoping review.

Irene Cartas-EspinelMarcelino Telechea-FernándezCarlos Manterola DelgadoAndrés Ávila BarreraNicolás Saavedra CuevasAngela L Riffo-Campos

Published in: ESC heart failure (2022)

Multiple studies presented a significant number of novel molecular biomarkers as promising predictors for risk assessment of cardiac dysfunction related to cancer therapy, but the characteristics of the studies carried out and the determinations applied do not allow suggesting the clinical use of these molecular biomarkers in the assessment of cancer therapy-induced cardiotoxicity.

Keyphrases

cancer therapy
drug delivery
risk assessment
high glucose
diabetic rats
drug induced
single molecule
left ventricular
endothelial cells
heavy metals
human health